Compounded, not FDA-approved
Enclomiphene raised testosterone in every major trial. The ads stop there. The record does not.
This molecule went the whole distance: phase III trials against testosterone gel, an FDA filing, an advisory committee date. Then FDA cancelled the vote and issued a complete response letter, Europe refused it over missing symptom evidence and clot risk, and the company sold for 67 cents a share. Today the same trials sell it as a compounded product. We publish the trials with their numbers, the two regulatory endings, the isomer pharmacology that makes it genuinely interesting, and the approved 1967 sibling it competes with.
- 48fetch-verified sources: 28 peer-reviewed, 20 government or registry
- 21studies in the graded evidence table, species labeled on every row
- 9primary regulatory documents quoted: FDA, EMA, Federal Register and SEC filings
- 19cited rows across the vs-clomiphene and vs-TRT comparison tables
Online care, from intake to delivery
Enclomiphene care, made simple
Choose your plan, complete a private medical intake, and connect with a licensed provider. If prescribed, treatment ships discreetly to your door.

Your care plan includes
Everything you need to get started
Encrypted checkout • provider review required • shipping included
- 01Choose your planSelect the supply and refill preference that works for you.
- 02Complete your intakeShare your health history in our private, secure flow.
- 03Provider reviewIf appropriate, your prescription is prepared and shipped.
Prescription treatment requires an online medical evaluation. A provider will determine whether treatment is medically appropriate; approval is not guaranteed.
Key facts
- StatusCompounded, not FDA-approved
- Half lifeAbout 7 hours for enclomiphene (serum half-life as cited in the published phase II report) h
- Isomer contrastZuclomiphene half-life is measured in days vs hours for enclomiphene (FDA PCAC meeting material); the Clomid label reports detectable zuclomiphene beyond a month and label residue in feces 6 weeks after dosing
- TmaxEnclomiphene tmax about 3 h vs zuclomiphene about 7 h after a single oral clomiphene dose h
- Exposure asymmetrySingle 50 mg clomiphene dose: zuclomiphene AUC 1289 vs enclomiphene AUC 65 ng/mL x h; on chronic clomiphene 25 mg daily the serum zu:en ratio is about 20:1
- WashoutEnclomiphene washes out within days (5 half-lives is about 35 hours); zuclomiphene remained urine-detectable 121 to more than 261 days after 30 days of clomiphene
- AbsorptionReadily absorbed orally in humans; excreted principally in feces (label pharmacokinetics for the mixed-isomer drug)
- MetabolismCYP2D6 is the primary enzyme metabolizing enclomiphene in vitro; quinidine abolished metabolism in human liver microsomes
- RouteOral capsules (12.5 mg and 25 mg were the strengths in the FDA-filed NDA); compounded products also sold as capsules and sublingual forms
- ClassSelective estrogen receptor modulator (SERM); trans-isomer of clomiphene
- Approved relativeClomiphene citrate (Clomid, NDA 016131, approved 1967, generics available), a 30-50% zuclomiphene mixture
- FormOral (capsules; 12.5 mg and 25 mg in the filed NDA)
- US regulatory endingFDA Complete Response Letter, December 1, 2015 (NDA 207959 not approvable in its filed form)
- EU regulatory endingEMA CHMP refusal of EnCyzix (enclomifene), January 25, 2018
- Serum half-lifeAbout 7 hours (vs a zuclomiphene half-life measured in days)
- Doses studied6.25, 12.5 and 25 mg daily in the Androxal program
- MoleculeC26H28ClNO, MW 406.0, CAS 15690-57-0 (PubChem CID 1548953)
- Development codesAndroxal (Repros Therapeutics); earlier codes RMI 16,289 and ICI 46476; EU trade name EnCyzix
Browse by topic
Everything on enclomiphene, organized the way you research it.
Free Enclomiphene tools
Practical calculators and references, each scoped and sourced.
Review-gated tools: these tools are excluded from search and AI citation and must not be used as hormone, fertility, monitoring, or treatment instruction.
All guides
65 in-depth, individually cited guides.
Review-gated archive: the guides below are preserved for individual medical and source review. They are excluded from search indexing and AI citation files.
Evidence 20 guides
Safety 15 guides
Sourcing 12 guides
Dosing 10 guides
Comparisons 8 guides
Follow the enclomiphene record as it changes
One short email when something real happens: FDA's compounding-list decision, a new trial, a safety action. Every item cited to its primary source.
